Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033288 · ClinicalTrials.gov registry record
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
A clinical trial of Chordoma and Chondrosarcoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 72
- Enrollment target
- 3
- Study locations
NCT05033288 is a study of Chordoma and Chondrosarcoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 72 participants, below the 82-participant average among 15 other Chordoma trials with a reported enrollment target (12% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05033288, a study of Chordoma and Chondrosarcoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three types of radiation treatment used for pelvic bone sarcomas: surgery with or without photon/proton therapy, proton therapy alone, and carbon ion therapy alone. The purpose of this study is to compare quality of life among patients treated for pelvic bone sarcomas across the world, and to determine if carbon ion therapy improves quality of life compared to surgery and disease control compared with proton therapy.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Electronic Health Record Review
Study Locations (3)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2031-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05033288
The ClinicalTrials.gov registry entry for NCT05033288 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 15 other Chordoma trials with a reported enrollment target (12% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Chordoma appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05033288 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05033288 about?
NCT05033288 is a clinical study titled "Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone". This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three types of radiation treatment used for pelvic bone sarcomas: surgery with or without photon/proton therapy, proton therapy alone, and carbon ion t...
What is the current status of trial NCT05033288?
This trial is currently recruiting. The enrollment target is 72 participants. The study started on 2022-01-20. Estimated completion is 2031-08-30.
What conditions does trial NCT05033288 study?
This clinical trial studies the following conditions: Chordoma, Chondrosarcoma, Bone Sarcoma, Ewing Sarcoma of Bone, Pelvic Rhabdomyosarcoma.
What interventions are being tested in trial NCT05033288?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05033288?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05033288 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chordoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Children and Adults With Chordoma
RECRUITING
-
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RECRUITING · Phase 1
-
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
RECRUITING · Phase 1
-
Pembrolizumab and Pemetrexed for Progressive Chordoma
RECRUITING · Phase 2
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
A Study of ERAS-601 in People With Chordoma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.